1. Home
  2. HD vs GILD Comparison

HD vs GILD Comparison

Compare HD & GILD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Home Depot Inc. (The)

HD

Home Depot Inc. (The)

HOLD

Current Price

$337.49

Market Cap

347.0B

ML Signal

HOLD

Logo Gilead Sciences Inc.

GILD

Gilead Sciences Inc.

HOLD

Current Price

$143.44

Market Cap

165.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HD
GILD
Founded
1978
1987
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
347.0B
165.0B
IPO Year
1999
2003

Fundamental Metrics

Financial Performance
Metric
HD
GILD
Price
$337.49
$143.44
Analyst Decision
Buy
Strong Buy
Analyst Count
23
18
Target Price
$423.00
$148.39
AVG Volume (30 Days)
3.5M
6.3M
Earning Date
05-19-2026
05-07-2026
Dividend Yield
2.89%
2.55%
EPS Growth
N/A
1684.21
EPS
3.30
N/A
Revenue
$66,176,000,000.00
$24,689,000,000.00
Revenue This Year
$7.13
$4.68
Revenue Next Year
$4.09
$6.04
P/E Ratio
$102.53
N/A
Revenue Growth
N/A
9.98
52 Week Low
$289.10
$108.46
52 Week High
$426.75
$157.29

Technical Indicators

Market Signals
Indicator
HD
GILD
Relative Strength Index (RSI) 48.69 69.57
Support Level $333.25 $142.93
Resistance Level $357.41 $149.38
Average True Range (ATR) 7.90 3.90
MACD -1.06 0.93
Stochastic Oscillator 37.43 96.80

Price Performance

Historical Comparison
HD
GILD

About HD Home Depot Inc. (The)

Home Depot is the world's largest home improvement specialty retailer, operating 2,361 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the US, Canada, and Mexico. Its stores offer building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of Interline Brands in 2015 allowed Home Depot to enter the MRO business, which has been expanded through the tie-up with HD Supply (2020). The 2024 tie-up with SRS will help grow professional demand in roofing, pool, and landscaping projects, while the 2025 purchase of GMS will lift building product sales through 1,250 distribution locations.

About GILD Gilead Sciences Inc.

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Share on Social Networks: